AI drug discovery company Genesis Therapeutics wins $200m in Series B round
Pharmaceutical Technology
AUGUST 21, 2023
The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.
Pharmaceutical Technology
AUGUST 21, 2023
The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.
pharmaphorum
DECEMBER 11, 2020
The companies said that the combination will strengthen their offering to pharmaceutical and biotech companies. The combined company will deliver data analytics, insights, business intelligence, virtual patient visits and hybrid technological solutions. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 4, 2023
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.
Pharmaceutical Technology
JUNE 4, 2023
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.
pharmaphorum
FEBRUARY 24, 2021
The health economic component of the revamped IPTs is informed by guidelines from the Grupo de Evaluación de Novedades, EStandarización e Investigación en Selección de Medicamentos (Group for the Evaluation of Innovations, Standardisation and Research in Drug Selection, GENESIS).
pharmaphorum
FEBRUARY 4, 2021
As COVID cases surged last year, lung cancer referrals dropped in the UK, causing alarm to the UK Lung Cancer Coalition (UKLCC), an alliance of the UK’s leading lung cancer experts, senior NHS professionals, charities, and healthcare companies.
ISPE
AUGUST 30, 2023
This workshop will provide participants with a comprehensive evaluation process and supporting assessment model for companies to evaluate their current status related to DT and identify areas of improvement and obstacles they may encounter on their way to mature their digital infrastructure.
Let's personalize your content